Cost-effectiveness of collaborative care for chronically ill patients with comorbid depressive disorder in the general hospital setting, a randomised controlled trial

BMC Health Services Research

Volumn 7, Issue , 2007, Pages

  Horn, Eva K ^a,d   Van Benthem, Tjeerd B ^b   Hakkaart Van Roijen, Leona ^c   Van Marwijk, Harm W J ^d   Beekman, Aartjan T F ^a,d,e   Rutten, Frans F ^c   Van Der Feltz Cornelis, Christina M ^a,d,e  

^a NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLASSIFICATION ALGORITHM; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DIABETES MELLITUS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; GENERAL HOSPITAL; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; NETHERLANDS; OUTCOME ASSESSMENT; OUTPATIENT CARE; PATIENT CARE; PROBLEM SOLVING; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SELF HELP; COST BENEFIT ANALYSIS; DEPRESSIVE DISORDER, MAJOR; ECONOMICS; MULTICENTER STUDY;

ANTIDEPRESSIVE AGENTS; CHRONIC DISEASE; COMORBIDITY; COST-BENEFIT ANALYSIS; DEPRESSIVE DISORDER, MAJOR; HUMANS; NETHERLANDS;

EID: 33847667417     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-7-28     Document Type: Article

References (112)

1. Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS). RV Bijl A Ravelli G van Zessen, Soc Psychiatry Psychiatr Epidemiol 1998 33 587 595 10.1007/s001270050098 9857791
2. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. CJ Murray AD Lopez, Lancet 1997 349 1498 1504 10.1016/S0140-6736(96)07492-2 9167458
3. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. RL Mikkelsen T Middelboe C Pisinger KB Stage, Nord J Psychiatry 2004 58 65 70 10.1080/08039480310000824 14985157
4. Diagnosis and pharmacological treatment of depressive disorders in a general hospital. MA Cigognini LM Furlanetto, Rev Bras Psiquiatr 2006 28 97 103 10.1590/S1516-44462006000200005 16810391
5. Depression in medical patients. R Peveler A Carson G Rodin, BMJ 2002 325 149 152 12130614 10.1136/bmj.325.7356.149
6. Prevalence of depression in older patients consulting their general practitioner in The Netherlands. E Licht-Strunk KG van der Kooij DJ van Schaik HW van Marwijk HP van Hout M de Haan, Int J Geriatr Psychiatry 2005 20 1013 1019 10.1002/gps.1391 16250082
7. Depression in general practice. A Al Windi, Nord J Psychiatry 2005 59 272 277 10.1080/08039480500227733 16195131
8. Evaluating psychiatric morbidity in a general hospital: a two-phase epidemiological survey. M Martucci M Balestrieri G Bisoffi P Bonizzato MG Covre L Cunico, Psychol Med 1999 29 823 832 10.1017/S0033291799008491 10473309
9. Competing demands from physical problems: effect on initiating and completing depression care over 6 months. PA Nutting K Rost J Smith JJ Werner C Elliot, Arch Fam Med 2000 9 1059 1064 10.1001/archfami.9.10.1059 11115208
10. Diabetes, depression, and quality of life: a population study. RD Goldney PJ Phillips LJ Fisher DH Wilson, Diabetes Care 2004 27 1066 1070 15111522
11. The costs of depression: direct and indirect; treatment versus nontreatment. PJ Panzarino Jr, J Clin Psychiatry 1998 59 Suppl 20 11 14 9881536
12. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. PS Ciechanowski WJ Katon JE Russo, Arch Intern Med 2000 160 3278 3285 10.1001/archinte.160.21.3278 11088090
13. Asthma symptoms associated with depression and lower quality of life: a population survey. RD Goldney R Ruffin LJ Fisher DH Wilson, Med J Aust 2003 178 437 441 12720509
14. Psychiatric Comorbidity and Functional Status in Adult Patients with Asthma. N Afari KB Schmaling S Barnhart D Buchwald, Journal of Clinical Psychology in Medical Settings 2001 8 245 252 10.1023/A:1011912712262
15. Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. JA Cully DP Graham MA Stanley CJ Ferguson A Sharafkhaneh J Souchek, Psychosomatics 2006 47 312 319 10.1176/appi.psy.47.4.312 16844889
16. Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. A Gehi D Haas S Pipkin MA Whooley, Arch Intern Med 2005 165 2508 2513 10.1001/archinte.165.21.2508 16314548
17. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. MR DiMatteo HS Lepper TW Croghan, Arch Intern Med 2000 160 2101 2107 10.1001/archinte.160.14.2101 10904452
18. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. WJ Katon, Biol Psychiatry 2003 54 216 226 10.1016/S0006-3223(03)00273-7 12893098
19. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. MJ Knol JW Twisk AT Beekman RJ Heine FJ Snoek F Pouwer, Diabetologia 2006 49 837 845 10.1007/s00125-006-0159-x 16520921
20. Association of depression and diabetes complications: a meta-analysis. M de Groot R Anderson KE Freedland RE Clouse PJ Lustman, Psychosom Med 2001 63 619 630 11485116
21. Hospitalization and mortality of diabetes in older adults. A 3-year prospective study. MJ Rosenthal M Fajardo S Gilmore JE Morley BD Naliboff, Diabetes Care 1998 21 231 235 9539987
22. Depressive symptoms and mortality among persons with and without diabetes. X Zhang SL Norris EW Gregg YJ Cheng G Beckles HS Kahn, Am J Epidemiol 2005 161 652 660 10.1093/aje/kwi089 15781954
23. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. J Barth M Schumacher C Herrmann-Lingen, Psychosom Med 2004 66 802 813 10.1097/01.psy.0000146332.53619.b2 15564343
24. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. JP van Melle P de Jonge TA Spijkerman JG Tijssen J Ormel DJ van Veldhuisen, Psychosom Med 2004 66 814 822 10.1097/01.psy.0000146294.82810.9c 15564344
25. Common mental disorders and use of general health services: a review of the literature on population-based studies. GT Koopmans MC Donker FH Rutten, Acta Psychiatr Scand 2005 111 341 350 10.1111/j.1600-0447.2005.00496.x 15819727
26. Increased medical costs of a population-based sample of depressed elderly patients. WJ Katon E Lin J Russo J Unutzer, Arch Gen Psychiatry 2003 60 897 903 10.1001/archpsyc.60.9.897 12963671
27. What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment. B Jonsson PE Bebbington, Br J Psychiatry 1994 164 665 673 7921718
28. Psychiatric issues in the management of patients with HIV infection. GJ Treisman AF Angelino HE Hutton, JAMA 2001 286 2857 2864 10.1001/jama.286.22.2857 11735762
29. CBO, Trimbos-instituut, Multidisciplinary Guideline Depressive disorder [Multidisciplinaire Richtlijn Depressie. In Dutch] Utrecht: Trimbos-instituut 2005
30. Treatment patterns and outcomes of depressed medically ill and non-medically ill patients in community psychiatric practice. P Stockton JJ Gonzales NP Stern SA Epstein, Gen Hosp Psychiatry 2004 26 2 8 10.1016/S0163-8343(03)00094-X 14757295
31. Improving depression outcomes in older adults with comorbid medical illness. LH Harpole JW Williams Jr MK Olsen KM Stechuchak E Oddone CM Callahan, Gen Hosp Psychiatry 2005 27 4 12 10.1016/j.genhosppsych.2004.09.004 15694213
32. Using what we know to better understand and treat depression. AJ Rush, The journal of the california alliance for the mentally ill 1998 9 9 11
33. Why is clinical depression so important? SE Hyman, The journal of the california alliance for the mentally ill 1998 9 11 13
34. Social and economic burden of mood disorders. GE Simon, Biol Psychiatry 2003 54 208 215 10.1016/S0006-3223(03)00420-7 12893097
35. Categorization of types of medical/psychiatry units based on level of acuity. RG Kathol HH Harsch RC Hall A Shakespeare T Cowart, Psychosomatics 1992 33 376 386 1461963
36. Integrating medical and psychiatric treatment in an inpatient medical setting. The type IV program. Y Kishi RG Kathol, Psychosomatics 1999 40 345 355 10402882
37. Disease management programs for depression: a systematic review and meta-analysis of randomized controlled trials. A Neumeyer-Gromen T Lampert K Stark G Kallischnigg, Med Care 2004 42 1211 1221 10.1097/00005650-200412000- 00008 15550801
38. Long-term effects of a collaborative care intervention in persistently depressed primary care patients. W Katon J Russo M Von Korff E Lin G Simon T Bush, J Gen Intern Med 2002 17 741 748 12390549 10.1046/j.1525-1497.2002.11051.x
39. Cost-effectiveness of enhancing primary care depression management on an ongoing basis. K Rost JM Pyne LM Dickinson AT LoSasso, Ann Fam Med 2005 3 7 14 15671185 10.1370/afm.256
40. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. J Unutzer W Katon CM Callahan JW Williams Jr E Hunkeler L Harpole, JAMA 2002 288 2836 2845 10.1001/jama.288.22. 2836 12472325
41. Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression. W Katon J Unutzer MY Fan JW Williams Jr M Schoenbaum EH Lin, Diabetes Care 2006 29 265 270 10.2337/diacare.29.02.06.dc05-1572 16443871
42. Depression in Adults with Diabetes. PJ Lustman LS Griffith RE Clouse, Semin Clin Neuropsychiatry 1997 2 15 23 10320439
43. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. RJ Anderson KE Freedland RE Clouse PJ Lustman, Diabetes Care 2001 24 1069 1078 11375373
44. Depression and cardiovascular disease: healing the broken-hearted. MA Whooley, JAMA 2006 295 2874 2881 10.1001/jama.295.24.2874 16804154
45. Anxiety and depression in COPD patients: The roles of gender and disease severity. F Di Marco M Verga M Reggente CF Maria P Santus F Blasi, Respir Med 2006 100 1767 1774 10.1016/j.rmed.2006.01.026 16531031
46. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. JA Ciesla JE Roberts, Am J Psychiatry 2001 158 725 730 10.1176/appi.ajp.158.5.725 11329393
47. The PHQ-9: validity of a brief depression severity measure. K Kroenke RL Spitzer JB Williams, J Gen Intern Med 2001 16 606 613 11556941 10.1046/j.1525-1497.2001.016009606.x
48. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. DV Sheehan Y Lecrubier KH Sheehan P Amorim J Janavs E Weiller, J Clin Psychiatry 1998 59 Suppl 20 22 33 9881538
49. De MINI-Internationaal neuropsychiatrisch interview: een kort gestructureerd diagnostisch interview voor DSM-IV en ICD-10 psychiatrische stoornissen. IM van Vliet H Leroy HJM van Megen, Leiden: LUMC 2000
50. A multifaceted intervention to improve treatment of depression in primary care. W Katon P Robinson M Von Korff E Lin T Bush E Ludman, Arch Gen Psychiatry 1996 53 924 932 8857869
51. Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. W Katon M Von Korff E Lin G Simon E Walker J Unutzer, Arch Gen Psychiatry 1999 56 1109 1115 10.1001/archpsyc.56.12. 1109 10591288
52. Collaborative management to achieve treatment guidelines. Impact on depression in primary care. W Katon M Von Korff E Lin E Walker GE Simon T Bush, JAMA 1995 273 1026 1031 10.1001/jama.273.13.1026 7897786
53. Improving primary care for depression in late life: the design of a multicenter randomized trial. J Unutzer W Katon JW Williams Jr CM Callahan L Harpole EM Hunkeler, Med Care 2001 39 785 799 10.1097/00005650-200108000-00005 11468498
54. Minder is meer. Stepped care in de geestelijke gezondheidszorg. JAC Meeuwissen MCH Doncker, Maandblad Geestelijke Volksgezondheid 2004 59 904 915
55. Randomised controlled trial of a collaborative care model with psychiatric consultation for persistent medically unexplained symptoms in general practice. CM Van der Feltz-Cornelis P van Oppen HJ Ader R van Dyck, Psychother Psychosom 2006 75 282 289 10.1159/000093949 16899964
56. Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. MH Trivedi AJ Rush ML Crismon TM Kashner MG Toprac TJ Carmody, Arch Gen Psychiatry 2004 61 669 680 10.1001/archpsyc.61.7.669 15237079
57. CM Van der Feltz-Cornelis, Psychiatric consultation for patients with somatoform disorder in general practice VU Amsterdam 2002
58. Evaluation of the adequacy of outpatient antidepressant treatment. JB Weilburg KM O'Leary JB Meigs J Hennen RS Stafford, Psychiatr Serv 2003 54 1233 1239 10.1176/appi.ps.54.9.1233 12954939
59. Psychopharmacologic treatment of depression in the medically ill. K Beliles A Stoudemire, Psychosomatics 1998 39 S2 19 9664784
60. Efficacy, predictors of therapy response, and safety of sertraline in routine clinical practice: prospective, open-label, non-interventional postmarketing surveillance study in 1878 patients. B Lowe I Schenkel MJ Bair C Gobel, J Affect Disord 2005 87 271 279 10.1016/j.jad.2005.05.005 15979151
61. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. DL Musselman E Betan H Larsen LS Phillips, Biol Psychiatry 2003 54 317 329 10.1016/S0006-3223(03)00569-9 12893107
62. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates? M Fava CH Mallinckrodt MJ Detke JG Watkin MM Wohlreich, J Clin Psychiatry 2004 65 521 530 15119915
63. Problem solving and behavior modification. TJ D'Zurilla MR Goldfried, J Abnorm Psychol 1971 78 107 126 10.1037/h0031360 4938262
64. Problem-solving. K Hawton J Kirk, Cognitive behaviour therapy for psychiatric problems Oxford: Oxford University Press, Hawton K, Salkovskis P, Kirk K, Clark D, 1989 406 426
65. A randomised controlled trial and cost analysis of problem-solving treatment for emotional disorders given by community nurses in primary care. L Mynors-Wallis I Davies A Gray F Barbour D Gath, Br J Psychiatry 1997 170 113 119 9093498
66. Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. LM Mynors-Wallis DH Gath AR Lloyd-Thomas D Tomlinson, BMJ 1995 310 441 445 7873952
67. Minimal-contact psychotherapy for sub-threshold depression in primary care. Randomised trial. GR Willemse F Smit P Cuijpers BG Tiemens, Br J Psychiatry 2004 185 416 421 10.1192/bjp.185.5.416 15516551
68. American Psychiatric Association, DSM-IV-TR Washington DC: American Psychiatric Association 2000
69. Sleep impairment in patients with painful diabetic peripheral neuropathy. DC Zelman NA Brandenburg M Gore, Clin J Pain 2006 22 681 685 10.1097/01.ajp.0000210910.49923.09 16988563
70. Sleep problems, health-related quality of life, work functioning and health care utilization among the chronically ill. M Manocchia S Keller JE Ware, Qual Life Res 2001 10 331 345 10.1023/A:1012299519637 11763246
71. Exercise Therapy for patients with psychiatric disorders: Research and clinical implications. GA Tkachuk GL Martin, Professional Psychology: Research and Practice 1999 30 275 282 10.1037/0735-7028.30.3.275
72. Effects of exercise and stress management training on markers of cardiovascular risk in patients with ischemic heart disease: a randomized controlled trial. JA Blumenthal A Sherwood MA Babyak LL Watkins R Waugh A Georgiades, JAMA 2005 293 1626 1634 10.1001/jama.293.13.1626 15811982
73. High-intensity resistance training improves glycemic control in older patients with type 2 diabetes. DW Dunstan RM Daly N Owen D Jolley Court De J Shaw, Diabetes Care 2002 25 1729 1736 12351469
74. Evidence for prescribing exercise as therapy in chronic disease. BK Pedersen B Saltin, Scand J Med Sci Sports 2006 16 Suppl 1 3 63 10.1111/j.1600-0838.2006.00520.x 16451303
75. Are mood disorders and obesity related? A review for the mental health professional. SL McElroy R Kotwal S Malhotra EB Nelson PE Keck CB Nemeroff, J Clin Psychiatry 2004 65 634 51 15163249
76. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. KP Su SY Huang CC Chiu WW Shen, Eur Neuropsychopharmacol 2003 13 267 271 10.1016/S0924-977X(03)00032-4 12888186
77. Current clinical applications of omega-6 and omega-3 fatty acids. S Lee KM Gura S Kim DA Arsenault BR Bistrian M Puder, Nutr Clin Pract 2006 21 323 341 16870801
78. Fat food for a bad mood. Could we treat and prevent depression in Type 2 diabetes by means of omega-3 polyunsaturated fatty acids? A review of the evidence. F Pouwer G Nijpels AT Beekman JM Dekker RM van Dam RJ Heine, Diabet Med 2005 22 1465 1475 10.1111/j.1464-5491.2005.01661.x 16241908
79. DA Dillman, Mail and Internet Surveys: The Tailored Design Method New York: John Wiley and Sons 2 2000
80. Prevalence and impact of depression and pain in neurology outpatients. LS Williams WJ Jones J Shen RL Robinson M Weinberger K Kroenke, J Neurol Neurosurg Psychiatry 2003 74 1587 1589 10.1136/jnnp.74.11.1587 14617727
81. The Inventory of Depressive Symptomatology (IDS): psychometric properties. AJ Rush CM Gullion MR Basco RB Jarrett MH Trivedi, Psychol Med 1996 26 477 486 8733206
82. Medical inpatients at risk of extended hospital stay and poor discharge health status: detection with COMPRI and INTERMED. P de Jonge I Bauer FJ Huyse CH Latour, Psychosom Med 2003 65 534 541 10.1097/01.PSY.0000077504.01963.1B 12883102
83. Clinical features of depressed outpatients with and without co-occurring general medical conditions in STAR*D. WR Yates J Mitchell AJ Rush MH Trivedi SR Wisniewski D Warden, Gen Hosp Psychiatry 2004 26 421 429 10.1016/j.genhosppsych.2004.06.008 15567207
84. Measurement of depression in patients with cancer. J Endicott, Cancer 1984 53 2243 2249 6704912
85. Depression and diabetes symptom burden. EJ Ludman W Katon J Russo M Von Korff G Simon P Ciechanowski, Gen Hosp Psychiatry 2004 26 430 436 10.1016/j.genhosppsych.2004.08.010 15567208
86. Monitoring depression treatment outcomes with the patient health questionnaire-9. B Lowe J Unutzer CM Callahan AJ Perkins K Kroenke, Med Care 2004 42 1194 1201 10.1097/00005650-200412000-00006 15550799
87. L Hakkaart-van Roijen, Manual Trimbos/iMTA questionnaire for costs associated with psychiatric illness (in Dutch) Rotterdam: Institute for Medical Technology Assessment 2002
88. Cost-utility of brief psychological treatment for depression and anxiety. LH van Roijen A van Straten M Al F Rutten M Donker, Br J Psychiatry 2006 188 323 329 10.1192/bjp.188.4.323 16582058
89. Euroqol group, Eq-5D user guide Rotterdam: Sanders instituut, EUR 1995
90. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. JE Ware Jr CD Sherbourne, Med Care 1992 30 473 483 10.1097/00005650-199206000-00002 1593914
91. The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. LM Lamers J McDonnell PF Stalmeier, Health economics 2006 15 1121 1132 10.1002/hec.1124 16786549
92. Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff. LM Lamers PF Stalmeier J McDonnell, Ned Tijdschr Geneeskd 2005 149 1574 1578 16038162
93. Lichamelijke Klachten Vragenlijst. AM Hemert, Leiden, Leids Universitair Medisch Centrum 2003 Ref Type: Report
94. A new approach to the assessment of the treatment effects of somatoform disorders. W Rief W Hiller, Psychosomatics 2003 44 492 498 10.1176/appi.psy.44. 6.492 14597684
95. A validation study of the Whitely Index, the Illness Attitude Scales, and the Somatosensory Amplification Scale in general medical and general practice patients. AE Speckens P Spinhoven PP Sloekers JH Bolk AM van Hemert, J Psychosom Res 1996 40 95 104 10.1016/0022-3999(95)00561-7 8730649
96. Dimensions of hypochondriasis. I Pilowsky, Br J Psychiatry 1967 113 89 93 6029373
97. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. EM Smets B Garssen B Bonke JC De Haes, J Psychosom Res 1995 39 315 325 10.1016/0022-3999(94)00125-O 7636775
98. Reliability and validity of the Multidimensional Fatigue Inventory (MFI-20) and the Rhoten Fatigue Scale among rural cancer outpatients. RA Schneider, Cancer Nurs 1998 21 370 373 10.1097/00002820-199810000-00009 9775488
99. WHO, Disability Assessment Schedule II (WHO-DAS-II), brief version pilot, interviewer's manual Geneva: WHO 1998
100. MHM Van der Linden, De verstandhouding tussen cliënt en therapeut: een empirisch onderzoek naar de kwaliteit van de therapeutische werkrelatie en effect bij psychodynamische psychotherapie. (The relationship between therapist and client: an empirical investigation of the quality of the therapeutic relationship and the effect of psychodynamic psychotherapy.) 1994
101. The Revised Helping Alliance Questionnaire (HAq-II). Psychometric Properties. L Luborksy JP Barber L Siqueland S Johnson LM Najavits A Frank, Journal of Psychotherapy Practice and Research 1996 5 260 271
102. General practitioners and depression first use of the depression attitude questionnaire. N Botega R Blizard DG Wilkinson A Mann, International Journal of Methods for Psychiatric Research 1992 4 169 180
103. Do general practitioners' attitudes towards depression predict their clinical behaviour? C Dowrick L Gask R Perry C Dixon T Usherwood, Psychol Med 2000 30 413 419 10.1017/S0033291799001531 10824661
104. The Social Readjustment Rating Scale. TH Holmes RH Rahe, J Psychosom Res 1967 11 213 218 10.1016/0022-3999(67)90010-4 6059863
105. HA Hoekstra F De Fruyt, NEO-PI-R en NEO-FFI: Big Five Persoonlijkheidsvragenlijsten: Handleiding Lisse: Swets & Zeitlinger 1996
106. JB Oostenbrink CAM Bouwmans MA Koopmanschap, Handleiding voor kostenonderzoek, methoden en standaardkostprijzen voor economische evaluaties in de gezondheidszorg. College voor zorgverzekeringen 2004
107. Labor and health status in economic evaluation of health care. The Health and Labor Questionnaire. L van Roijen ML Essink-Bot MA Koopmanschap, Int J Technol Assess Health Care 1996 12 405 415 8840661
108. Costeffectiveness of psychotherapy: A feasibility study (in Dutch). QD van Dam A Spijker LR Arends, Journal of Psychotherapy 1998 24 5 22
109. A practical guide for calculating indirect costs of disease. MA Koopmanschap FF Rutten, Pharmacoeconomics 1996 10 460 466 10172868
110. The friction cost method for measuring indirect costs of disease. MA Koopmanschap FF Rutten BM van Ineveld L van Roijen, J Health Econ 1995 14 171 189 10.1016/0167-6296(94)00044-5 10154656
111. Multiple imputation after 18+ years. DB Rubin, J Am Stat Assoc 1996 91 473 489 10.2307/2291635
112. Costs, effects and C/E-ratios alongside a clinical trial. BA van Hout MJ Al GS Gordon FF Rutten, Health Econ 1994 3 309 319 7827647